Cargando…
Impact of Empiric Antimicrobial Therapy on Outcomes in Patients with Escherichia coli and Klebsiella pneumoniae Bacteremia: A Cohort Study
BACKGROUND: It is unclear whether appropriate empiric antimicrobial therapy improves outcomes in patients with bacteremia due to Escherichia coli or Klebsiella. The objective of this study is to assess the impact of appropriate empiric antimicrobial therapy on in-hospital mortality and post-infectio...
Autores principales: | Thom, Kerri A, Schweizer, Marin L, Osih, Regina B, McGregor, Jessina C, Furuno, Jon P, Perencevich, Eli N, Harris, Anthony D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551598/ https://www.ncbi.nlm.nih.gov/pubmed/18793400 http://dx.doi.org/10.1186/1471-2334-8-116 |
Ejemplares similares
-
Empiric Antibiotic Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality: A Retrospective Cohort Study
por: Schweizer, Marin L., et al.
Publicado: (2010) -
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
por: Schweizer, Marin L, et al.
Publicado: (2011) -
No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia
por: Heng, Shi Thong, et al.
Publicado: (2018) -
Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae
por: Chaubey, Vikas P, et al.
Publicado: (2010) -
1508. Carbapenem vs. Non-carbapenem as Empiric Regimens for Bacteremia Caused by ESBL Producing Escherichia coli and Klebsiella pneumoniae in Children: Preliminary Study
por: Park, Saera, et al.
Publicado: (2019)